CVS Health Corp annual ebitda for fiscal TTM was $11.1 billion, an increase of 12.9% from $9.9 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EBITDA (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | $11.1B | $9.9B | $13.7B | $13.7B | $12.3B | $17.5B | $17.1B | $16.4B | $6.7B | $11.8B | $12.2B | $11.6B | $10.2B | $9.9B | $8.6B | $7.9B | $7.6B | $7.8B | $7.3B | $5.9B | $3.2B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EBITDA (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| EBITDA | $5.8B | $3.3B | ($1.6B) | $3.6B | $4.6B | $4.0B | $2.0B | $4.2B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CVS metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding
All CVS financial statements → Interactive CVS charts →
About TickerBase · Data methodology & sources